The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A genomic classifier for identifying a neuroendocrine-like bladder cancer subtype.
 
Jonathan L. Wright
Honoraria - UpToDate
Research Funding - Altor BioScience; Movember Foundation; Nucleix
 
Marc Dall'era
Honoraria - Genomic Health
Speakers' Bureau - Genomic Health; Photocure
Research Funding - GenomeDx
 
Trinity Bivalacqua
Honoraria - Photocure
 
Roland Seiler
Consulting or Advisory Role - GenomeDx
Patents, Royalties, Other Intellectual Property - Genomic Subtyping Classifier
 
Yang Liu
Employment - GenomeDx
 
Ewan Gibb
Employment - GenomeDx
 
Natalie Qiqi Wang
Employment - GenomeDx
 
Nicholas Erho
Employment - GenomeDx
 
Mohammed Alshalalfa
Employment - GenomeDx
 
Elai Davicioni
Employment - GenomeDx
Leadership - GenomeDx
Stock and Other Ownership Interests - GenomeDx
Patents, Royalties, Other Intellectual Property - CANCER DIAGNOSTICS USING BIOMARKERS 20140066323
Travel, Accommodations, Expenses - GenomeDx
 
Jason A. Efstathiou
Consulting or Advisory Role - Bayer; Genentech; Medivation/Astellas
 
James G. Douglas
No Relationships to Disclose
 
Joost L Boormans
Consulting or Advisory Role - Bristol-Myers Squibb; Janssen; Roche
Travel, Accommodations, Expenses - Astellas Oncology
 
Michiel Simon Van Der Heijden
Consulting or Advisory Role - Astellas Pharma (Inst); AstraZeneca/MedImmune (Inst); Bristol-Myers Squibb (Inst); Roche/Genentech (Inst)
Research Funding - Astellas Pharma (Inst)
Travel, Accommodations, Expenses - Astellas Pharma; MSD Oncology; Novartis
 
Yair Lotan
Consulting or Advisory Role - Augmenix; BioCancell; MDxhealth; pacific edge; Photocure; Physical Optics Corporation; SonaCare Medical
Research Funding - Abbott Molecular (Inst); Augmenix; Cepheid; Cepheid (Inst); Danone; GenomeDx (Inst); MDxHealth (Inst); pacific edge; pacific edge (Inst)
 
Peter C. Black
Consulting or Advisory Role - Abbvie; Allergan; Amgen; Astellas Pharma; Bayer; BioCancell; Biosyent; Cubist; Ferring; Janssen Oncology; Lilly; MDxHealth; Merck; Novartis; Roche Canada; Sanofi; Sitka; Spectrum Pharmaceuticals
Speakers' Bureau - Ferring; Red Leaf Medical
Research Funding - GenomeDx; iProgen; New B Innovation
Patents, Royalties, Other Intellectual Property - 1. PCT/CA2014/000787. Canada. 2014-11-03 Cancer Biomarkers and Classifiers and uses thereof. 2. #61899648 United States. 2013-03-13 Bladder cancer signature.
Travel, Accommodations, Expenses - Bayer; Janssen; Sanofi